Menlo Therapeutics
Why Robinhood?
You can watch MNLO and buy or sell other stocks, ETFs, and their options commission-free!About MNLO
Menlo Therapeutics is a clinical late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. We are concurrently evaluating the use of serlopitant for refractory chronic cough, a cough that persists for greater than eight weeks despite treatment of any identified underlying cause.
MNLO Key Statistics
Stock Snapshot
With a market cap of 116.63M, Menlo Therapeutics(MNLO) trades at $3.50. The stock has a price-to-earnings ratio of -0.92.
Menlo Therapeutics(MNLO) stock opened on 2026-04-04 at —. The price climbed to — and dipped to —.
The Menlo Therapeutics(MNLO)'s current trading volume is 0, compared to an average daily volume of 168.24K.
During the past year, Menlo Therapeutics(MNLO) stock moved between $0.28 at its lowest and $1.99 at its peak.
During the past year, Menlo Therapeutics(MNLO) stock moved between $0.28 at its lowest and $1.99 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.